HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients
- PMID: 20463072
- PMCID: PMC2898231
- DOI: 10.1128/JVI.02548-09
HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients
Abstract
The objective of this study was to estimate and compare the evolutionary rates of HIV-2 and HIV-1. Two HIV-2 data sets from patients with advanced disease were compared to matched HIV-1 data sets. The estimated mean evolutionary rate of HIV-2 was significantly higher than the estimated rate of HIV-1, both in the gp125 and in the V3 region of the env gene. In addition, the rate of synonymous substitutions in gp125 was significantly higher for HIV-2 than for HIV-1, possibly indicating a shorter generation time or higher mutation rate of HIV-2. Thus, the lower virulence of HIV-2 does not appear to translate into a lower rate of evolution.
Similar articles
-
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.Clin Microbiol Infect. 2015 Sep;21(9):873.e1-9. doi: 10.1016/j.cmi.2015.05.014. Epub 2015 May 21. Clin Microbiol Infect. 2015. PMID: 26003280 Clinical Trial.
-
Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model.J Virol. 2010 Mar;84(6):2740-52. doi: 10.1128/JVI.02180-09. Epub 2009 Dec 30. J Virol. 2010. PMID: 20042504 Free PMC article.
-
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response.Retrovirology. 2013 Oct 24;10:110. doi: 10.1186/1742-4690-10-110. Retrovirology. 2013. PMID: 24156513 Free PMC article.
-
Differences of HIV envelope protein between HIV-1 and HIV-2: possible relation to the lower virulence of HIV-2.Viral Immunol. 1998;11(1):1-8. doi: 10.1089/vim.1998.11.1. Viral Immunol. 1998. PMID: 9586692 Review. No abstract available.
-
[Origin and evolution of human immunodeficiency viruses].Bacteriol Virusol Parazitol Epidemiol. 2009 Oct-Dec;54(4):167-76. Bacteriol Virusol Parazitol Epidemiol. 2009. PMID: 20923120 Review. Romanian.
Cited by
-
Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.Clin Exp Immunol. 2019 Jun;196(3):305-317. doi: 10.1111/cei.13280. Epub 2019 Mar 21. Clin Exp Immunol. 2019. PMID: 30773620 Free PMC article. Review.
-
Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.mBio. 2019 Jan 8;10(1):e01245-18. doi: 10.1128/mBio.01245-18. mBio. 2019. PMID: 30622192 Free PMC article.
-
Engineering broadly neutralizing antibodies for HIV prevention and therapy.Adv Drug Deliv Rev. 2016 Aug 1;103:157-173. doi: 10.1016/j.addr.2016.01.013. Epub 2016 Jan 29. Adv Drug Deliv Rev. 2016. PMID: 26827912 Free PMC article. Review.
-
Variation in Intra-individual Lentiviral Evolution Rates: a Systematic Review of Human, Nonhuman Primate, and Felid Species.J Virol. 2019 Jul 30;93(16):e00538-19. doi: 10.1128/JVI.00538-19. Print 2019 Aug 15. J Virol. 2019. PMID: 31167917 Free PMC article.
-
Phylogenetic reconstruction of the initial stages of the spread of the SARS-CoV-2 virus in the Eurasian and American continents by analyzing genomic data.Virus Res. 2021 Nov;305:198551. doi: 10.1016/j.virusres.2021.198551. Epub 2021 Aug 26. Virus Res. 2021. PMID: 34454972 Free PMC article.
References
-
- Alatrakchi, N., F. Damond, S. Matheron, S. Beretta-Tempelhoff, P. Campa, G. Carcelain, F. Brun-Vezinet, and B. Autran. 2006. Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection. AIDS 20:29-34. - PubMed
-
- Andersson, S., H. Norrgren, Z. da Silva, A. Biague, S. Bamba, S. Kwok, C. Christopherson, G. Biberfeld, and J. Albert. 2000. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch. Intern. Med. 160:3286-3293. - PubMed
-
- Barroso, H., and N. Taveira. 2005. Evidence for negative selective pressure in HIV-2 evolution in vivo. Infect. Genet. Evol. 5:239-346. - PubMed
-
- Bjorling, E., G. Scarlatti, A. von Gegerfelt, J. Albert, G. Biberfeld, F. Chiodi, E. Norrby, and E. M. Fenyo. 1993. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 193:528-530. - PubMed
-
- Borrego, P., J. M. Marcelino, C. Rocha, M. Doroana, F. Antunes, F. Maltez, P. Gomes, C. Novo, H. Barroso, and N. Taveira. 2008. The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients. Retrovirology 5:78. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical